Regenerve Review: A Targeted Approach to Diabetic Neuropathy

For millions living with diabetic neuropathy, the standard explanation has long been a single, frustrating diagnosis: nerve damage from high blood sugar. Patients are often given a short list of medications designed to mute the pain, with little discussion of what is actually happening inside the body. Regenerve, a physician-led clinic in St. Louis directed by Dr. Gurpreet Singh Padda, is challenging that status quo. On World Diabetes Day, Dr. Padda presented a compelling argument that what is routinely called one problem is actually three distinct mechanisms, each requiring a different conversation and a different treatment plan.

This distinction is not academic. As Dr. Padda explains, a patient describing burning in both feet could be suffering from a compression that is correctable, a perfusion deficit that is modifiable, or years of accumulated glycation that is not. By treating all three the same way, clinicians help only one patient by accident. Regenerve’s approach is to identify which mechanism is at work and direct care accordingly, setting honest expectations from the start. The result is a model of care that is both more precise and more compassionate.

What is Regenerve?

Regenerve is an advanced peripheral neuropathy treatment center located in St. Louis, Missouri. It is a DBA of the Interventional Center for Pain Management, P.C., and serves patients from Missouri and Illinois. The clinic is led by Dr. Gurpreet Singh Padda, a board-certified pain physician whose training spans anesthesiology, pain medicine, interventional pain management, addiction medicine, and obesity medicine. This combination of credentials is rare, and it directly informs the clinic’s approach to neuropathy.

The clinic’s philosophy is that peripheral neuropathy is rarely one disease. It is often a combination of starving blood flow, unstable blood sugar, autoimmune attack, and low nutrients stacked on top of one another. A physician who treats only the pain signal will manage the symptom forever but never touch the cause. Regenerve aims to address the underlying cause through targeted diagnostic testing and individualized treatment plans.

What stands out

Mechanism-based diagnosis

Regenerve begins with on-site electrodiagnostic testing, including nerve conduction studies and needle electromyography. This establishes whether a nerve is compressed, metabolically injured, or both, and precisely localizes the problem. This is a far cry from the standard approach of simply asking about symptoms.

Targeted treatment options

Once the mechanism is identified, treatment is directed at the specific problem. Options include peripheral or vagal nerve stimulation, endoscopic decompression where entrapment is present, photobiomodulation, and infusion therapy addressing metabolic and oxidative drivers. Nutritional and metabolic care are also integral parts of the plan.

Honest communication about prognosis

Dr. Padda treats setting honest expectations as the more important half of the exercise. A perfusion problem and an entrapment have different ceilings from an accumulated glycation burden. Telling a patient which one they have is more useful than telling them their sugars need to improve, especially when the biology is slower than the lab results suggest.

Who it’s for

Regenerve is for anyone with diabetic or prediabetic neuropathy who has grown frustrated with a one-size-fits-all explanation. It is also for patients who have been told their neuropathy is irreversible and want a second opinion from a physician who understands the difference between a starving nerve and a destroyed one. The clinic’s approach is particularly valuable for those who have tried standard medications without success, or who have been managing symptoms for years without understanding the underlying cause.

It is also for patients who have experienced the frustration of improving their glucose control only to see no improvement in their nerve symptoms. Dr. Padda’s explanation of the legacy effect—where glycation is cumulative and slow to reverse—provides a framework for understanding why symptoms can persist even after numbers improve. This is not an argument against control, but an argument against promising that improved numbers will retroactively undo a burden laid down years before.

What makes it worth considering

What makes Regenerve worth considering is the depth of its diagnostic capability and the breadth of its treatment options. Most neuropathy patients have seen physicians who hold one view of the problem—focusing on pain signals, blood sugar, or structural issues alone. Few have seen a physician who holds all of these views at once. Dr. Padda’s multiple board certifications allow him to see the full picture, from the metabolic origins of nerve damage to the mechanical consequences of lost protective sensation.

Another factor is the clinic’s willingness to address the hardest conversation in neuropathy care: the patient who has done everything right and still has symptoms. By explaining that the nerve is reporting on a fifteen-year record, not just the last three months, Regenerve offers patients a realistic and empowering understanding of their condition. This honesty is more useful than a generic prescription, and it sets the stage for a treatment plan that addresses the actual mechanism at work.

Pricing and availability

Pricing for Regenerve’s services is not publicly listed, as treatment plans are individualized based on diagnostic findings and the specific mechanisms involved. The clinic is located at 4477 Woodson Road #104, St. Louis, MO 63134, minutes from St. Louis Lambert International Airport. They serve patients from Missouri and Illinois. For specific pricing and insurance questions, contacting the clinic directly is recommended.

Verdict

Regenerve offers a forward-thinking, mechanism-based approach to diabetic neuropathy that moves beyond a one-size-fits-all diagnosis. With advanced diagnostics, targeted treatments, and honest communication about prognosis, it stands out as a valuable resource for patients seeking real answers. The clinic’s physician-led model, backed by multiple board certifications, provides a level of expertise rarely found in neuropathy care.